Back to Top
 

 

 

 

 

 

 

 

 

 

Patient Access Network Foundation Opens New Funds for Patients Living with Inherited Retinal Disease

 

For Immediate Release

PAN Foundation Contact:

Margaret Figley, Director of Communications

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.


Washington, DC, (February 7, 2018) - The Patient Access Network (PAN) Foundation today opened three new assistance funds for patients living with inherited retinal disease. Qualifying patients will be eligible for grants to help cover the out-of-pocket costs associated with their prescribed inherited retinal medications, insurance premiums and required travel costs related to their inherited retinal disease treatment.

“The PAN Foundation is excited to be able to help patients with the out-of-pocket treatment, travel and insurance premium costs related to their inherited retinal disease,” said PAN President and CEO Daniel Klein. “We are committed to easing patients’ financial burdens so that they can access the critical medications they need to best manage their conditions and focus on improving their health and quality of life.”

Patients who qualify for the PAN Foundation’s Inherited Retinal Disease Programs must be getting treatment for inherited retinal disease; must reside and receive treatment in the United States; must have health insurance; and the medication for which they seek assistance must be covered by their insurance and must be listed on PAN’s list of covered medications. In addition, patients must fall at or below 500 percent of the Federal Poverty Level. Patients who are eligible for the Inherited Retinal Disease Travel Program must be required to travel more than 20 miles (one way) to receive their prescribed treatment (exceptions to distance requirements are made for patients living in large metropolitan cities). 

PAN’s travel assistance covers approved transportation, lodging and ancillary travel expenses. Qualifying patients will receive a travel debit card and can use that card to make travel arrangements to and from medical treatments.

See below for information related to each program’s assistance amount.



Patients, or advocates and caregivers applying on their behalf, can apply for assistance using the PAN Foundation’s online patient portal (www.panapply.org), or by calling 1-866-316-7263, 9 a.m. to 7 p.m. Eastern Time, Monday through Friday. To learn more about PAN’s over 60 disease-specific programs, visit panfoundation.org.

About the PAN Foundation:
The PAN Foundation is an independent, nationwide 501(c)3 organization dedicated to providing help and hope to underinsured patients who are unable to afford the out-of-pocket expenses for their prescribed medications. Since 2004, PAN has provided over $3 billion in financial assistance to nearly 1 million patients who would otherwise be unable to afford their medications. To learn more, visit www.panfoundation.org.

 

 

Patient Access Network Foundation Opens New Hemophilia Patient Assistance Fund

 

For Immediate Release

PAN Foundation Contact:

Margaret Figley, Director of Communications

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Washington, DC, (January 9, 2018) - The Patient Access Network (PAN) Foundation today opened a new patient assistance program for people living with hemophilia. Hemophilia is a rare, inherited bleeding disorder in which blood does not clot properly due to low levels of proteins called “clotting factors.” Qualifying patients are eligible to receive grants for the out-of-pocket costs associated with their hemophilia treatment insurance premiums.

“The PAN Foundation is excited to alleviate the financial strain of the out-of-pocket premium costs for people living with hemophilia,” said PAN President and CEO Daniel Klein. “Thanks to our generous donors, many patients living with hemophilia will be able to access the treatment they need to best manage their conditions and focus on improving their health and quality of life.”

Patients who qualify for the PAN Foundation’s Hemophilia Premium Assistance Program are eligible to receive $4,500 per year in financial assistance. Eligible patients must be getting treatment for hemophilia; must reside and receive treatment in the United States; must have health insurance; and the medication for which they seek assistance must be covered by their insurance and must be listed on PAN’s list of covered medications. In addition, patients must fall at or below 400 percent of the Federal Poverty Level.

Patients, or advocates and caregivers applying on their behalf, can apply for assistance using the PAN Foundation’s online patient portal (www.panapply.org), or by calling 1-866-316-7263, 9 a.m. to 7 p.m. Eastern Time, Monday through Friday. To learn more about PAN’s more than 60 disease-specific programs, visit panfoundation.org.

About the PAN Foundation:

The PAN Foundation is an independent, nationwide 501(c)3 organization dedicated to providing help and hope to underinsured patients who are unable to afford the out-of-pocket expenses for their prescribed medications. Since 2004, PAN has provided over $2.6 billion in financial assistance to nearly 1 million underinsured patients who would otherwise be unable to afford their medications. To learn more, visit www.panfoundation.org.

Patient Access Network Foundation Opens New Pulmonary Hypertension Patient Assistance Fund

 

For Immediate Release

PAN Foundation Contact:

Margaret Figley, Director of Communications

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Washington, DC, (January 2, 2018) - The Patient Access Network (PAN) Foundation today opened a new patient assistance program for patients living with pulmonary hypertension, a type of high blood pressure that affects the arteries connecting the heart to the lungs. Qualifying patients will be eligible for grants to help cover the out-of-pocket costs associated with their prescribed pulmonary hypertension medications.

“Thanks to the generosity and support of our donors, the PAN Foundation is able to alleviate the financial strain of the out-of-pocket treatment costs for people living with pulmonary hypertension,” said PAN President and CEO Daniel Klein. “The PAN team is committed to easing patients’ financial burdens so that they can access the critical medications they need to best manage their conditions and focus on improving their health and quality of life.”

Patients who qualify for the PAN Foundation’s Pulmonary Hypertension Assistance Program are eligible to receive $5,300 per year in financial assistance. Eligible patients must be getting treatment for pulmonary hypertension; must reside and receive treatment in the United States; must have Medicare health insurance; and the medication for which they seek assistance must be covered by their insurance and must be listed on PAN’s list of covered medications. In addition, patients must fall at or below 500 percent of the Federal Poverty Level.

Patients, or advocates and caregivers applying on their behalf, can apply for assistance using the PAN Foundation’s online patient portal (www.panapply.org), or by calling 1-866-316-7263, 9 a.m. to 7 p.m. Eastern Time, Monday through Friday. To learn more about PAN’s more than 60 disease-specific programs, visit panfoundation.org.

About the PAN Foundation:

The PAN Foundation is an independent, nationwide 501(c)3 organization dedicated to providing help and hope to underinsured patients who are unable to afford the out-of-pocket expenses for their prescribed medications. Since 2004, PAN has provided over $2.6 billion in financial assistance to nearly 1 million underinsured patients who would otherwise be unable to afford their medications. To learn more, visit www.panfoundation.org.

PAN Foundation Featured in Forbes’ 100 Largest U.S. Charities

 

The PAN Foundation is featured in Forbes’ 100 Largest U.S. Charities for 2017 list, ranking as the 23rd largest charity in the country.

 

 

 

 

Patient Access Network Foundation Opens New Acute Myeloid Leukemia Patient Assistance Fund

 

For Immediate Release

PAN Foundation Contact:

Margaret Figley, Director of Communications

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Washington, DC, (June 16, 2017) - The Patient Access Network (PAN) Foundation today opened a new patient assistance program for Medicare patients with acute myeloid leukemia (AML). Qualifying patients are eligible to receive grants for their out-of-pocket costs associated with their prescribed AML medications.

“The PAN Foundation is pleased to support people living with acute myeloid leukemia,” said PAN President and CEO Daniel Klein. “When people—and their families—receive a diagnosis like AML, the financial implications can be tremendous. We are committed to finding ways to ease those financial burdens, so that people living with acute myeloid leukemia can focus on feeling better, getting through their treatments and hopefully recovering.”

Patients who qualify for the PAN Foundation’s AML program are eligible to receive up to $5,500 per year in financial assistance. Eligible patients must be getting treatment for AML; must reside and receive treatment in the United States; must have Medicare health insurance; and the medication for which they seek assistance must be covered by Medicare and must treat the disease directly. In addition, patients must fall at or below 500 percent of the Federal Poverty Level.

Patients, or advocates and caregivers applying on their behalf, can apply for assistance using the PAN Foundation’s online patient portal (www.panapply.org), or by calling 1-866-316-7263, 9 a.m. to 5 p.m. Eastern Time, Monday through Friday. To learn more about PAN’s more than 50 disease-specific programs, visit panfoundation.org.

 

About the PAN Foundation:

The PAN Foundation is an independent, nationwide 501(c)3 organization dedicated to providing help and hope to underinsured patients who are unable to afford the out-of-pocket expenses for their prescribed medications. Since 2004, PAN has provided over $2.5 billion in financial assistance to more than 700,000 patients who would otherwise be unable to afford their medications. To learn more, visit www.panfoundation.org.